Greece defaults on its debt, imposes capital controls, threatens to blow up the whole EU experiment, and gold is flat on the day? Gold is now material for making jewelry and plating the ends of audio cables. It's not money, it's not a safe haven, it's a shiny industrial metal. Enjoy your shiny industrial metal. It will never be valued higher than it is today. Banksters win, gold bugs lose. The end.
This is remarkable. More than 50% of the public float is now being shorted. Many of those shares are naked short. I think what we saw the past few days was just a sneak preview of what's coming. MNKD could go bananas to the upside.
I'm sorry. I'm as big a MNKD bull as there is, but where are you getting $45 billion from? If 10% of diabetics (2.5 million) go on Afrezza and pay $2500 per year on Afrezza, the revenue is closer to $6 billion. $45 billion in the US seems impossible.
CNBC made an enormous mistake turning over mornings to that egomaniac. He is literally unwatchable. And unlistenable on SIRIUS, where his idiocy is fully exposed for what it is. Now that Maria B. is doing mornings, I think CNBC will be in a world of hurt.
The rebels launched an assault west of Donetsk. Russia is invading again. More sanctions coming. RSX to 10, as predicted on another thread after we failed at 23.
RSX is not following oil now. Oil was up big Friday and RSX was down. They don't always follow each other. RSX failed at resistance and now will fall all the way back to 10.
Parsley was slammed twice in the span of two minutes, dropping 30 cents each time at 11:27 and 11:28AM on no news and light volume. SEC is asleep at the switch -- again!
I bought ABX Oct 16 calls a few weeks ago when Barrick was $12.62. I paid 45 cents. It's down 2.5%, and the options are down 64%. Seems a bit excessive to me for an out-of-the-money call, but I guess WS knows best!
When a mining exploration company makes a big discovery, the stock pops, and then it tends to drift lower as reality sets in that it takes years and billions of dollars to build an operating mine. Investors lose interest and the stock flounders for a while, sometimes years as the company raises capital, finds a JV partner, and then goes about building the mine. The stock usually bottoms just before production begins, and that's the best time to buy, just before things start getting really good. Mannkind reminds me of an exploration company about to begin production. The stock has plummeted at exactly the moment investors should be getting the most excited and earnings are just around the corner. So sit tight and be right!
I like your numbers better. I don't remember where I saw the 175 million number. According to the American Diabetes Association, as of 2012 there were 29.1 million diabetics and 21 million diagnosed cases. Since the US is around 5 percent of total world population, my 175m figure is probably pretty accurate. If you have a better source, please cite it. 5% of total diabetics (and remember, 25-30% of them will be undiagnosed if US is any guide) using Afrezza would be a huge victory for this drug. Let's get to 5% penetration first.
Yes, by 2030 there will be many more diabetics. Unfortunately, the patents on the Afrezza inhaler runs out around 2032 unless they can extend the patents. I'm not banking on that.
Why is it a recipe for disaster? We have only one real asset: Technosphere. Why not just maximize that asset by collecting tax-free royalties on its use?
I am not a tax expert by any means, but I'm wondering if we can farm-out the manufacturing of Afrezza to a spinco, which MNKD does at-cost anyway, and collect our share of the gross profit from SNY as a tax-free royalty. Any ideas if this is possible?